<table id="table7" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7: Proportion of Subjects with less than 50 HIV-1 RNA copies per mL at Week 48 by Baseline Number of IAS-USA-Defined NNRTI Substitutions in the Non-VF Excluded Population of the Pooled TMC125-C206 and TMC125-C216 Trials</caption>
<col align="center" span="1" valign="top" width="33%"></col>
<col align="center" span="1" valign="top" width="33%"></col>
<col align="center" span="1" valign="top" width="34%"></col>
<tbody>
<tr>
<th colspan="1"># IAS-USA-Defined NNRTI substitutions<linkhtml href="#footnote-1">*</linkhtml>
</th>
<th colspan="2">Etravirine Arms<br/>N = 561</th>
</tr>
<tr>
<th colspan="1"></th>
<th colspan="1">Re-Used/Not Used Enfuvirtide</th>
<th colspan="1">De Novo Enfuvirtide</th>
</tr>
<tr>
<td>
<content stylecode="bold">All ranges</content>
</td>
<td>61% (254/418)</td>
<td>76% (109/143)</td>
</tr>
<tr>
<td>
<content stylecode="bold">0</content>
</td>
<td>68% (52/76)</td>
<td>95% (20/21)</td>
</tr>
<tr>
<td>
<content stylecode="bold">1</content>
</td>
<td>67% (72/107)</td>
<td>77% (24/31)</td>
</tr>
<tr>
<td>
<content stylecode="bold">2</content>
</td>
<td>64% (75/118)</td>
<td>86% (38/44)</td>
</tr>
<tr>
<td>
<content stylecode="bold">3</content>
</td>
<td>55% (36/65)</td>
<td>62% (16/26)</td>
</tr>
<tr>
<td>
<content stylecode="bold">â‰¥ 4</content>
</td>
<td>37% (19/52)</td>
<td>52% (11/21)</td>
</tr>
<tr>
<td></td>
<td>
<content stylecode="bold">Placebo Arms</content>
<br/>
<content stylecode="bold">N = 592</content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">All ranges</content>
</td>
<td>34% (147/435)</td>
<td>59% (93/157)</td>
</tr>
</tbody>
</table>